| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 47.381 | 56.642 | 130.079 | 210.621 | 143.071 | 234.424 | 286.518 | 268.101 | 253.244 |
| Total Income - EUR | - | 47.381 | 56.642 | 130.079 | 210.621 | 143.071 | 234.424 | 286.518 | 268.101 | 253.250 |
| Total Expenses - EUR | - | 45.198 | 53.756 | 122.137 | 197.296 | 140.755 | 208.772 | 280.803 | 244.504 | 223.421 |
| Gross Profit/Loss - EUR | - | 2.182 | 2.885 | 7.942 | 13.324 | 2.317 | 25.652 | 5.715 | 23.597 | 29.829 |
| Net Profit/Loss - EUR | - | 761 | 1.186 | 6.641 | 11.218 | 1.002 | 23.355 | 2.907 | 21.238 | 23.005 |
| Employees | - | 2 | 2 | 3 | 4 | 4 | 5 | 4 | 4 | 4 |
Check the financial reports for the company - Vegibioseb Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 168 | 89 | 82 | 35 | 635 | 19.592 | 15.922 | 12.155 | 14.611 |
| Current Assets | - | 3.189 | 8.875 | 18.216 | 35.509 | 29.731 | 56.322 | 47.890 | 71.652 | 58.598 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 589 | 3.949 | 8.781 | 7.910 | 4.062 | 10.369 | 14.941 | 12.001 | 19.071 |
| Cash | - | 2.600 | 4.927 | 9.434 | 27.599 | 25.669 | 45.954 | 32.950 | 59.650 | 39.527 |
| Shareholders Funds | - | 805 | 1.978 | 8.582 | 14.851 | 10.610 | 28.150 | 4.739 | 25.963 | 24.821 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.551 | 6.986 | 9.715 | 20.693 | 19.756 | 47.764 | 59.074 | 57.844 | 48.388 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4631 - 4631" | |||||||||
| CAEN Financial Year |
4631
|
|||||||||
Comments - Vegibioseb Srl